For informational purposes only — not investment advice

← Back to signals

SSP

E.W. SCRIPPS Co

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)
6.3d↓-6.7%
as of 2026-10-15

News Summary

Negative

E.W. Scripps reported Q2 2026 revenue of $490M with a massive $1.1B non-cash goodwill impairment charge, resulting in a $12.68 loss per share, though underlying operations showed expense discipline. The company is aggressively executing a transformation plan involving 431 job cuts (6% of workforce), centralized production, and automation, targeting $125-150M EBITDA growth by 2028, with political advertising as a bright spot.

Red flags

  • •$1.1B goodwill and intangible asset impairment charge in Q2 indicates prior acquisition overpayment and raises asset quality concerns
  • •Revenue declined from Q1 ($517M) to Q2 ($490M); full-year revenue tracking down 14.2% YoY on trailing basis
  • •Net income deeply negative at -$1.28B; EPS at -$14.25 reflects severe profitability challenges
  • •6% workforce reduction (431 positions) suggests structural challenges requiring substantial restructuring; second wave of layoffs in 2026 indicates ongoing distress
  • •Leverage remains elevated at 3.9x net leverage despite cost-cutting efforts
  • •Analyst price targets show extreme dispersion ($1.50-$10.00) and consensus is 'Hold' with mixed conviction, reflecting high uncertainty

Fund 13D/13G Filings (1)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

FundForm∆ Shares% of ClassSince FilingFiledSrc
Point72SC 13GNEW5.2%
+17.2% vs SPY
+12.1% abs
2026-10-05↗